Company / PP&E per Share
Kymera Therapeutics, Inc. PP&E per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.67
FY2025
5-year range
$0.26 / $1.00
FY2021-FY2025
Trend
-26.7%
vs FY2024
Sector context
#53 of 191
Health Care
What the data says
At $0.67, Kymera Therapeutics, Inc.'s pp&e per share ranks #53 of 191 in the Health Care sector. PP&E per Share has fluctuated over the past 7 years, ranging from $0.26 in FY2022 to $5.62 in FY2020.
Based on SEC 10-K filings.
0.67 in FY2025 with a 5-year CAGR of -34.7%.
Declined from $1.00 to $0.67 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +37.0%
- 5-Year CAGR
- -34.7%
- 10-Year CAGR
- -
Sector benchmark
#53 of 191 in Health CareTop 28% of 191This company $0.67 Sector average $18.90
▼
-96.5% below sector average
Key checks
Key Insights
- In FY2025, pp&e per share decreased 26.7% year-over-year.
- Ranks #53 out of 191 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2020.
- Lowest pp&e per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 3.27 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.67 | -26.7% |
| FY2024 | $0.91 | -9.5% |
| FY2023 | $1.00 | +287.7% |
| FY2022 | $0.26 | -3.1% |
| FY2021 | $0.27 | -95.2% |
| FY2020 | $5.62 | +151.5% |
| FY2019 | $2.23 | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 30, 2026